Non-contrast Abbreviated MRI for Secondary Surveillance of HCC

CompletedOBSERVATIONAL
Enrollment

210

Participants

Timeline

Start Date

December 28, 2021

Primary Completion Date

June 22, 2024

Study Completion Date

June 22, 2024

Conditions
Hepatocellular Carcinoma
Interventions
DIAGNOSTIC_TEST

non-contrast abbreviated MRI

"Liver MRI without contrast injection. The following sequences will be obtained from all of the participants.~* Axial heavily and regular T2 WI~* precontrast fat-suppressed T1 WI~* Diffusion-weighted image using b-value of 0, 50 or 400, and 800 or 1000"

DIAGNOSTIC_TEST

Contrast enhanced liver CT

"Liver CT with iodine contrast injection This test will be served as a standard diagnostic test. The following phases will be obtained~* precontast, arterial phase, portal venous phase and delayed phase"

Trial Locations (3)

13620

Seoul National University Bundang Hospital, Seongnam

05505

Asan Medical Center, Seoul

03080

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT05690451 - Non-contrast Abbreviated MRI for Secondary Surveillance of HCC | Biotech Hunter | Biotech Hunter